₩46,200.00
0.87% yesterday
Korea, Oct 15, 08:10 am CET
ISIN
KR7302440003
Symbol
302440
Index

SK Bioscience Stock price

₩46,200.00
-5,700.00 10.98% 1M
+6,900.00 17.56% 6M
-4,200.00 8.33% YTD
-9,900.00 17.65% 1Y
-27,700.00 37.48% 3Y
-122,800.00 72.66% 5Y
-122,800.00 72.66% 10Y
-122,800.00 72.66% 20Y
Korea, Closing price Wed, Oct 15 2025
+400.00 0.87%
ISIN
KR7302440003
Symbol
302440
Index
Industry

Key metrics

Basic
Market capitalization
₩3.6t
Enterprise Value
₩2.9t
Net debt
positive
Cash
₩1.1t
Shares outstanding
78.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
6.7 | 5.7
EV/Sales
5.4 | 4.6
EV/FCF
negative
P/B
2.0
Financial Health
Equity Ratio
63.4%
Return on Equity
-3.0%
ROCE
-5.0%
ROIC
-3.8%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
₩534.9b | ₩628.6b
EBITDA
₩-114.7b | ₩-5.8b
EBIT
₩-127.5b | ₩-116.3b
Net Income
₩-52.7b | ₩-58.5b
Free Cash Flow
₩-215.9b
Growth (TTM | estimate)
Revenue
44.0% | 135.0%
EBITDA
-1,240.2% | 95.5%
EBIT
-3,946.5% | 16.0%
Net Income
-292.1% | -8.6%
Free Cash Flow
-1,318.6%
Margin (TTM | estimate)
Gross
8.5%
EBITDA
-21.4% | -0.9%
EBIT
-23.8%
Net
-9.9% | -9.3%
Free Cash Flow
-40.4%
More
EPS
₩-671.7
FCF per Share
₩-2,754.8
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is SK Bioscience a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

SK Bioscience Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a SK Bioscience forecast:

1x Buy
9%
4x Hold
36%
6x Sell
55%

Analyst Opinions

11 Analysts have issued a SK Bioscience forecast:

Buy
9%
Hold
36%
Sell
55%

Financial data from SK Bioscience

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
534,914 534,914
44% 44%
100%
- Direct Costs 489,437 489,437
130% 130%
91%
45,477 45,477
71% 71%
9%
- Selling and Administrative Expenses 110,367 110,367
69% 69%
21%
- Research and Development Expense 65,181 65,181
20% 20%
12%
-114,662 -114,662
1,240% 1,240%
-21%
- Depreciation and Amortization 12,840 12,840
90% 90%
2%
EBIT (Operating Income) EBIT -127,501 -127,501
3,947% 3,947%
-24%
Net Profit -52,696 -52,696
292% 292%
-10%

In millions KRW.

Don't miss a Thing! We will send you all news about SK Bioscience directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

SK bioscience Co., Ltd. engages in the development and distribution of bio and vaccine products. The company was founded on July 1, 2018 and is headquartered in Seongnam-si, South Korea.

Head office South Korea
CEO Jae-Yong An
Founded 2008
Website www.skbioscience.co.kr

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today